These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17030701)

  • 21. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
    Ridker PM
    J Am Coll Cardiol; 2007 May; 49(21):2129-38. PubMed ID: 17531663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging cardiovascular risk factors in end-stage renal disease.
    Yaqoob MM
    J Nephrol; 2002; 15(2):205-8. PubMed ID: 12018642
    [No Abstract]   [Full Text] [Related]  

  • 24. C-reactive protein: "cutoff" point and clinical applicability.
    Tsirpanlis G; Alevyzaki F; Triantafyllis G; Chatzipanagiotou S; Nicolaou C
    Am J Kidney Dis; 2005 Aug; 46(2):368; author reply 369. PubMed ID: 16112061
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemokines in cardiovascular risk prediction.
    Aukrust P; Yndestad A; Smith C; Ueland T; Gullestad L; Damås JK
    Thromb Haemost; 2007 May; 97(5):748-54. PubMed ID: 17479185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting cardiovascular complications after liver transplantation: 007 to the rescue?
    Liu H; Lee SS
    Liver Transpl; 2011 Jan; 17(1):7-9. PubMed ID: 21254338
    [No Abstract]   [Full Text] [Related]  

  • 27. Is there a need for novel cardiovascular risk factors?
    von Eckardstein A
    Nephrol Dial Transplant; 2004 Apr; 19(4):761-5. PubMed ID: 15031325
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does inflammation influence cardiovascular risk factor modification?
    Milani RV; Lavie CJ
    Circulation; 2004 Feb; 109(5):e29; author reply e29. PubMed ID: 14769691
    [No Abstract]   [Full Text] [Related]  

  • 30. Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease.
    Hurks R; Peeters W; Derksen WJ; Hellings WE; Hoefer IE; Moll FL; de Kleijn DP; Pasterkamp G
    Thromb Haemost; 2009 Jan; 101(1):48-54. PubMed ID: 19132188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory markers for risk stratification in primary prevention of cardiovascular disease: time for a 'multimarker' approach?
    Ikonomidis I; Lekakis J; Kremastinos DT
    Thromb Haemost; 2006 Mar; 95(3):397-8. PubMed ID: 16525564
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis.
    Ranjit N; Diez-Roux AV; Shea S; Cushman M; Seeman T; Jackson SA; Ni H
    Arch Intern Med; 2007 Jan; 167(2):174-81. PubMed ID: 17242319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking interacts with sleep apnea to increase cardiovascular risk.
    Lavie L; Lavie P
    Sleep Med; 2008 Mar; 9(3):247-53. PubMed ID: 17513169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD; Rifai N
    Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein: from acute phase reactant to cardiovascular disease risk factor.
    Woodhouse S
    MLO Med Lab Obs; 2002 Mar; 34(3):12-3, 16, 19-20; quiz 20-1. PubMed ID: 11926095
    [No Abstract]   [Full Text] [Related]  

  • 36. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
    Olsson AG
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
    [No Abstract]   [Full Text] [Related]  

  • 37. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of inflammatory factors and cardiac troponin T in hemodialysis patients.
    Falaknazi K; Bagheri N; Taziki O
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):219-22. PubMed ID: 19237807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of CRP in coronary risk determination.
    Mehta JL; Sukhija R; Romeo F; Sepulveda JL
    Indian Heart J; 2007; 59(2):173-7. PubMed ID: 19122252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity C-reactive protein in every chart? The use of biomarkers in individual patients.
    Ben-Yehuda O
    J Am Coll Cardiol; 2007 May; 49(21):2139-41. PubMed ID: 17531664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.